Antti Lindgren

Antti Lindgren

Auto-generated profile, based on publicly available information

Antti Lindgren

Neurosurgery, NeuroCenter, Kuopio University Hospital, Kuopio, Finland

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2020 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
HSHunt All-In Stroke
Hunt All-In Stroke
MBMark K. Bakker
Mark K. Bakker
CGChina Kadoorie Biobank Collaborative Group
China Kadoorie Biobank Collaborative Group
BCBioBank Japan Project Consortium
BioBank Japan Project Consortium
TGThe ICAN Study Group
The ICAN Study Group
YRYnte Ruigrok
Ynte Ruigrok

25 April 2017 in Neurology
Verified
Journal Article
Closed access
PDF file
DBDaan Backes
Daan Backes
GRGabriel J.E. Rinkel
Gabriel J.E. Rinkel
JGJacoba P. Greving
Jacoba P. Greving
BVBirgitta K. Velthuis
Birgitta K. Velthuis
YMYuichi Murayama
Yuichi Murayama
MVMervyn D.I. Vergouwen
Mervyn D.I. Vergouwen
Objective: To develop a risk score that estimates 3-year and 5-year absolute risks for aneurysm growth. Methods: From 10 cohorts of patients with unruptured intracranial aneurysms and follow-up imaging, we pooled individual data on sex, population, age, hypertension, history of subarachnoid hemorrhage, and aneurysm location, size, aspect ratio, and shape but not on smoking during follow-up and family history of intracranial aneurysms in 1,507 patients with 1,909 unruptured intracranial aneurysms and used aneurysm growth as outcome. With aneurysm-based multivariable Cox regression analysis, we determined predictors for aneurysm growth, which were presented as a risk score to calculate 3-year and 5-year risks for aneurysm growth by risk factor status. Results: Aneurysm growth occurred in 257 patients (17%) and 267 aneurysms (14%) during 5,782 patient-years of follow-up. Predictors for aneurysm growth were earlier subarachnoid hemorrhage, location of the aneurysm, age >60 years, population, size of the aneurysm, and shape of the aneurysm (ELAPSS). The 3-year growth risk ranged from 42% and the 5-year growth risk from 60%, depending on the risk factor status. Conclusions: The ELAPSS score consists of 6 easily retrievable predictors and can help physicians in decision making on the need for and timing of follow-up imaging in patients with unruptured intracranial aneurysms.

1 March 2019 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
AAAnnemijn M. Algra
Annemijn M. Algra
ALAntti Lindgren
Antti Lindgren
MVMervyn D. I. Vergouwen
Mervyn D. I. Vergouwen
JGJacoba P. Greving
Jacoba P. Greving
ISIrene C. van der Schaaf
Irene C. van der Schaaf
GRGabriel J. E. Rinkel
Gabriel J. E. Rinkel
The prevalence of saccular unruptured intracranial aneurysms (UIAs) in the general population is 3%.1 Owing to the rising availability and quality of brain imaging, the number of incidentally discovered UIAs is increasing.2,3 Many UIAs remain asymptomatic, but some rupture, causing subarachnoid hemorrhage (SAH). This is a subtype of stroke with a poor prognosis (a case-fatality rate of approximately 35%), often affecting relatively young patients (mean age, 60 years).4 Preventive treatment of UIAs, either by endovascular treatment (EVT) or neurosurgical treatment (NST), can decrease the risk of SAH, but both treatment modalities carry a risk of serious complications.5 Currently, the decision to treat UIAs is a balance of risk of rupture, risk of treatment complications, life expectancy, and level of patient anxiety. For estimations of the rupture risk, prediction models are available that provide absolute risks of rupture for the next 5 years based on a few easily available risk factors.6,7 Such robust data are lacking for the estimation of complication risk from UIA treatment.5,8 The best available evidence comes from meta-analyses published in 2012 and 2013 on the procedural morbidity and case-fatality risk of EVT and NST.9,10 However, since the publication of these reviews, there has been a further shift toward EVT as the predominant treatment modality, with an increasing variety of advanced endovascular methods being used, such as stent-assisted or balloon-assisted coiling, flow-diverting stents, and Woven EndoBridge (WEB) Aneurysm Embolization devices. In addition, previous meta-analyses did not focus on risk factors for complications apart from subgroup analyses. Our aim is to provide an overview of the recent literature on EVT and NST, with several new focuses. In addition to assessing the procedural 30-day clinical complication and case-fatality risks of both treatment modalities, we conducted a meta-analysis of the available risk factor data for clinical complications from both EVT and NST, and we separately assess the complication risk of advanced endovascular methods that were increasingly applied in clinical practice over the last few years.

1 May 2016 in Stroke
Verified
Journal Article
Closed access
PDF file
ALAntti E. Lindgren
Antti E. Lindgren
TKTimo Koivisto
Timo Koivisto
JBJoel Björkman
Joel Björkman
MFMikael von Und zu Fraunberg
Mikael von Und zu Fraunberg
KHKatariina Helin
Katariina Helin
JFJuhana Frösen
Juhana Frösen
Background and Purpose—: Size and shape of saccular intracranial aneurysms (sIA) reflect the condition of the sIA wall and were risk factors for rupture in previous follow-up studies. We investigated how well size or shape identify rupture-prone sIAs. Methods—: In a population-based registry, we investigated the characteristics of ruptured sIAs treated in a single neurosurgical center (1980–2014). In addition to univariate analysis, logistic regression was used in multivariate analysis, and sensitivity and specificity of size or shape were calculated using receiver operating characteristic curves. Results—: Ruptured sIAs were on average larger than unruptured sIAs (median, 7 versus 4 mm; P <0.000), but location and patient background affected the size at rupture. Of the ruptured sIAs, 38% were smaller than 7 mm and 18% were smaller than 4 mm. Of those sIAs that had ruptured at a small (<7 mm) size, 87% had an irregular shape. In multivariate analysis, irregular shape had the strongest association with presentation as ruptured sIA (odds ratio, 7.1; 95% confidence interval, 6.0–8.3), with better sensitivity (91%) and specificity (76%), in contrast to smoking (odds ratio, 0.7; 95% confidence interval, 0.6–0.9; sensitivity, 28%; specificity 57%) and Population, Hypertension, Age, Size of sIA, Earlier SAH from another sIA, Site of sIA score (odds ratio, 1.5; 95% confidence interval, 1.4–1.6). Conclusions—: Irregular or multilobular shape is strongly associated with rupture in sIAs of all sizes and independent of location and patient background. Especially sIAs with irregular shape should be considered as high rupture risk lesions, even if small in diameter and in nonsmoking patients with low PHASES scores.

15 August 2018 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
ALAntti Lindgren
Antti Lindgren
MVMervyn Di Vergouwen
Mervyn Di Vergouwen
ISIrene Van Der Schaaf
Irene Van Der Schaaf
AAAle Algra
Ale Algra
MWMarieke Wermer
Marieke Wermer
GRGabriel Je Rinkel
Gabriel Je Rinkel

3 June 2022 in European Stroke Journal
Verified
Journal Article
Closed access
NENima Etminan
Nima Etminan
DSDiana Aguiar de Sousa
Diana Aguiar de Sousa
CTCindy Tiseo
Cindy Tiseo
RBRomain Bourcier
Romain Bourcier
HDHubert Desal
Hubert Desal
GRGabriel Je Rinkel
Gabriel Je Rinkel
Unruptured intracranial aneurysms (UIA) occur in around 3% of the population. Important management questions concern if and how to perform preventive UIA occlusion; if, how and when to perform follow up imaging and non-interventional means to reduce the risk of rupture. Using the Standard Operational Procedure of ESO we prepared guidelines according to GRADE methodology. Since no completed randomised trials exist, we used interim analyses of trials, and meta-analyses of observational and case-control studies to provide recommendations to guide UIA management. All recommendations were based on very low evidence. We suggest preventive occlusion if the estimated 5-year rupture risk exceeds the risk of preventive treatment. In general, we cannot recommend endovascular over microsurgical treatment, but suggest flow diverting stents as option only when there are no other low-risk options for UIA repair. To detect UIA recurrence we suggest radiological follow up after occlusion. In patients who are initially observed, we suggest radiological monitoring to detect future UIA growth, smoking cessation, treatment of hypertension, but not treatment with statins or acetylsalicylic acid with the indication to reduce the risk of aneurysm rupture. Additionally, we formulated 15 expert-consensus statements. All experts suggest to assess UIA patients within a multidisciplinary setting (neurosurgery, neuroradiology and neurology) at centres consulting >100 UIA patients per year, to use a shared decision-making process based on the team recommendation and patient preferences, and to repair UIA only in centres performing the proposed treatment in >30 patients with (ruptured or unruptured) aneurysms per year per neurosurgeon or neurointerventionalist. These UIA guidelines provide contemporary recommendations and consensus statement on important aspects of UIA management until more robust data come available.